Lung-residing metastatic and dormant neuroblastoma cells

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 524-536

  Edry Botzer, Liat ^a   Maman, Shelly ^a   Sagi Assif, Orit ^a   Meshel, Tzipi ^a   Nevo, Ido ^a   Bäuerle, Tobias ^b   Yron, Ilana ^a   Witz, Isaac P ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INVASION; CARCINOGENICITY; CELL MIGRATION; CONTROLLED STUDY; DISSEMINATED NEUROBLASTOMA CELL; DORMANCY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG METASTATIC NEUROBLASTOMA CELL; MICROENVIRONMENT; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SINGLE CELL ANALYSIS; SYSTEMATIC REVIEW;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE MARROW NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM, RESIDUAL; NEUROBLASTOMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE;

EID: 80052492863     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.020     Document Type: Article

References (56)

1. D. Mullassery, C. Dominici, E.C. Jesudason, H.P. McDowell, and P.D. Losty Neuroblastoma: contemporary management Arch Dis Childhood-E 94 2009 177 185
2. S. Modak, and N.K.V. Cheung Neuroblastoma: therapeutic strategies for a clinical enigma Cancer Treat Rev 36 2010 307 317
3. J.M. Maris, M.D. Hogarty, R. Bagatell, and S.L. Cohn Neuroblastoma Lancet 369 2007 2106 2120
4. G.M. Brodeur Neuroblastoma Amsterdam edition 2000 Elsevier New York 1 583
5. F. Cowie, R. Corbett, and C.R. Pinkerton Lung involvement in neuroblastoma: incidence and characteristics Med Pediatr Oncol 28 1997 429 432
6. B.F. Kammen, K.K. Matthay, P. Pacharn, R. Gerbing, R.C. Brasch, and C.A. Gooding Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis AJR Am J Roentgenol 176 2001 755 759
7. C.P. Reynolds Detection and treatment of minimal residual disease in high-risk neuroblastoma Pediatr Transplant 8 2004 56 66
8. G.M. Brodeur Neuroblastoma: biological insights into a clinical enigma Nat Rev Cancer 3 2003 203 216
9. T. Kuroda, N. Morikawa, K. Matsuoka, A. Fujino, T. Honna, A. Nakagawa, M. Kumagai, H. Masaki, and M. Saeki Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma J Pediatr Surg 43 2008 2182 2185
10. H. Geminder, O. Sagi-Assif, L. Goldberg, T. Meshel, G. Rechavi, I.P. Witz, and A. Ben-Baruch A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma J Immunol 167 2001 4747 4757
11. I. Nevo, O. Sagi-Assif, T. Meshel, H. Geminder, L. Goldberg-Bittman, S. Ben-Menachem, B. Shalmon, I. Goldberg, A. Ben-Baruch, and I.P. Witz The tumor microenvironment: cXCR4 is associated with distinct protein expression patterns in neuroblastoma cells Immunol Lett 92 2004 163 169
12. I. Nevo, O. Sagi-Assif, T. Meshel, A. Ben-Baruch, K. Johrer, R. Greil, L.E. Trejo, O. Kharenko, M. Feinmesser, I. Yron, and I.P. Witz The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells Cancer Lett 273 2009 127 139
13. L. Goldberg-Bittman, O. Sagi-Assif, T. Meshel, I. Nevo, O. Levy-Nissenbaum, I. Yron, I.P. Witz, and A. Ben-Baruch Cellular characteristics of neuroblastoma cells: regulation by the ELRCXC chemokine CXCL10 and expression of a CXCR3-like receptor Cytokine 29 2005 105 117
14. I. Nevo, O. Sagi-Assif, L. Edry Botzer, D. Amar, S. Maman, N. Kariv, L.E. Leider-Trejo, L. Savelyeva, M. Schwab, I. Yron, and I.P. Witz Generation and characterization of novel local and metastatic human neuroblastoma variants Neoplasia 10 2008 816 827
15. I. Nevo, A. Oberthuer, E. Botzer, O. Sagi-Assif, S. Maman, M. Pasmanik-Chor, N. Kariv, M. Fischer, I. Yron, and I.P. Witz Gene-expression- based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients Int J Cancer 126 2010 1570 1581
16. T. Pietsch, E. Gottert, E. Meese, N. Blin, H.J. Feickert, H. Riehm, and G. Kovacs Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma Anticancer Res 8 1988 1329 1333
17. P. Parham, C.J. Barnstable, and W.F. Bodmer Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens J Immunol 123 1979 342 349
18. K. Ozato, and D.H. Sachs Monoclonal antibodies to mouse MHC antigens III Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression J Immunol 126 1981 317 321
19. M.J. Warzynski, D.M. Graham, R.A. Axtell, J.V. Higgins, and Y.A. Hanmers Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients Cytometry 50 2002 298 304
20. M.J. Warzynski, D.M. Graham, R.A. Axtell, J.V. Higgins, and Y.A. Hammers Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients Cytometry 42 2000 324 325
21. B. Kagedal Detecting minimal residual disease in neuroblastoma: still a ways to go Clin Chem 55 2009 1268 1270
22. T. Fehm, V. Muller, C. Alix-Panabieres, and K. Pantel Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance Breast Cancer Res 10 Suppl 1 2008 S1
23. J. Donovan, J. Temel, A. Zuckerman, J. Gribben, J.J. Fang, G. Pierson, A. Ross, L. Diller, and S.A. Grupp CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies Medical and Pediatric Oncology 35 2000 677 682
24. A.W. Wognum, A.C. Eaves, and T.E. Thomas Identification and isolation of hematopoietic stem cells Arch Med Res 34 2003 461 475
25. R. Luo, J. Gao, B. Wehrle-Haller, and P.D. Henion Molecular identification of distinct neurogenic and melanogenic neural crest sublineages Development 130 2003 321 330
26. H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraser, and H.I. Kornblum Cancerous stem cells can arise from pediatric brain tumors P Natl Acad Sci USA 100 2003 15178 15183
27. M. Gaviraghi, P. Tunici, S. Valensin, M. Rossi, C. Giordano, L. Magnoni, M. Dandrea, L. Montagna, R. Ritelli, A. Scarpa, and A. Bakker Pancreatic cancer spheres are more than just aggregates of stem marker positive cells Biosci Rep 31 2010 45 55
28. S. Riethdorf, H. Wikman, and K. Pantel Review: biological relevance of disseminated tumor cells in cancer patients Int J Cancer 123 2008 1991 2006
29. V. Orian-Rousseau CD44, a therapeutic target for metastasising tumours Eur J Cancer 46 2010 1271 1277
30. I. Airoldi, C. Cocco, F. Morandi, I. Prigione, and V. Pistoia CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow Cancer Immunol Immun 57 2008 541 548
31. N. Gross, and R. Meier Chemokines in neuroectodermal cancers: the crucial growth signal from the soil Semin Cancer Biol 19 2009 103 110
32. L. Raffaghello, C. Cocco, M.V. Corrias, I. Airoldi, and V. Pistoia Chemokines in neuroectodermal tumour progression and metastasis Semin Cancer Biol 19 2009 97 102
33. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501
34. S. Brader, and S.A. Eccles Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis Tumori 90 2004 2 8
35. D.X. Nguyen, P.D. Bos, and J. Massague Metastasis: from dissemination to organ-specific colonization Nat Rev Cancer 9 2009 274 284
36. R. Roy, J. Yang, and M.A. Moses Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer J Clin Oncol 27 2009 5287 5297
37. S. Fulda, M. Honer, I. Menke-Moellers, and F. Berthold Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro Eur J Cancer 31A 1995 616 621
38. C. Coghlin, and G.I. Murray Current and emerging concepts in tumour metastasis J Pathol 222 2010 1 15
39. K. Pantel, and C. Alix-Panabieres Circulating tumour cells in cancer patients: challenges and perspectives Trends Mol Med 16 2010 398 406
40. K. Pantel, and C. Alix-Panabieres The clinical significance of circulating tumor cells Nat Clin Pract Oncol 4 2007 62 63
41. Y. Husemann, J.B. Geigl, F. Schubert, P. Musiani, M. Meyer, E. Burghart, G. Forni, R. Eils, T. Fehm, G. RiethmUller, and C.A. Klein Systemic spread is an early step in breast cancer Cancer Cell 13 2008 58 68
42. C. Alix-Panabieres, S. Riethdorf, and K. Pantel Circulating tumor cells and bone marrow micrometastasis Clin Cancer Res 14 2008 5013 5021
43. J.A. Aguirre-Ghiso Models, mechanisms and clinical evidence for cancer dormancy Nat Rev Cancer 7 2007 834 846
44. G.N. Naumov, I.C. MacDonald, P.M. Weinmeister, N. Kerkvliet, K.V. Nadkarni, S.M. Wilson, V.L. Morris, A.C. Groom, and A.F. Chambers Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy Cancer Res 62 2002 2162 2168
45. E. Viala, and J. Pouyssegur Regulation of tumor cell motility by ERK mitogen-activated protein kinases Ann NY Acad Sci 1030 2004 208 218
46. R.A. Ross, and B.A. Spengler Human neuroblastoma stem cells Semin Cancer Biol 17 2007 241 247
47. Q.S. Tong, L.D. Zheng, S.T. Tang, Q.L. Ruan, Y. Liu, S.W. Li, G.S. Jiang, and J.B. Cai Expression and clinical significance of stem cell marker CD133 in human neuroblastoma World J Pediatr 4 2008 58 62
48. L.M. Hansford, A.E. McKee, L. Zhang, R.E. George, J.T. Gerstle, P.S. Thorner, K.M. Smith, A.T. Look, H. Yeger, F.D. Miller, M.S. Irwin, C.J. Thiele, and D.R. Kaplan Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell Cancer Res 67 2007 11234 11243
49. W.A. Woodward, and E.P. Sulman Cancer stem cells: markers or biomarkers? Cancer Metastasis Rev 27 2008 459 470
50. Z. Kuci, G. Seitz, S. Kuci, H. Kreyenberg, M. Schumm, P. Lang, D. Niethammer, R. Handgretinger, and G. Bruchelt Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic cells Anticancer Res 26 2006 2075 2080
51. V.F. Viprey, M.V. Corrias, B. Kagedal, S. Oltra, K. Swerts, A. Vicha, R. Ladenstein, and S.A. Burchill Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET Eur J Cancer 43 2007 341 350
52. J. Stutterheim, A. Gerritsen, L. Zappeij-Kannegieter, I. Kleijn, R. Dee, L. Hooft, M.M. van Noesel, M. Bierings, F. Berthold, R. Versteeg, H.N. Caron, C.E. van der Schoot, and G.A. Tytgat PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma J Clin Oncol 26 2008 5443 5449
53. G.N. Naumov, J.L. Townson, I.C. MacDonald, S.M. Wilson, V.H. Bramwell, A.C. Groom, and A.F. Chambers Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases Breast Cancer Res Treat 82 2003 199 206
54. M.A. Essers, and A. Trumpp Targeting leukemic stem cells by breaking their dormancy Mol Oncol 4 2010 443 450
55. H. Enderling, L. Hlatky, and P. Hahnfeldt Migration rules: tumours are conglomerates of self-metastases Br J Cancer 100 2009 1917 1925
56. O. Schmidt-Kittler, T. Ragg, A. Daskalakis, M. Granzow, A. Ahr, T.J. Blankenstein, M. Kaufmann, J. Diebold, H. Arnholdt, P. Muller, J. Bischoff, D. Harich, G. Schlimok, G. Riethmuller, R. Eils, and C.A. Klein From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression Proc Natl Acad Sci USA 100 2003 7737 7742